Xos (XOS) director plans 30,000-share sale after $44K trades

Rhea-AI Filing Summary

Xos, Inc. (symbol XOS) received a notice that director Stuart Bernstein intends to sell up to 30,000 shares of Xos common stock under Rule 144, with UBS Financial Services Inc. listed as broker. The shares are tied to RSU vesting on 06/22/2026.

The notice also lists prior sales by Bernstein over the preceding three months totaling 12,000 shares of common stock on various dates in May and June 2026 for aggregate proceeds of $44,812. A reference line shows 30,000 shares with an aggregate market value of $124,500 and a related figure of 14,217,852 as of 08/18/2026, presented as context for the planned sale.

Key Figures

Planned shares to be sold: 30,000 shares Aggregate market value of planned sale: $124,500 Context share figure: 14,217,852 shares +5 more

8 metrics

Planned shares to be sold 30,000 shares Maximum Xos common shares indicated for sale under Rule 144

Aggregate market value of planned sale $124,500 Contextual aggregate market value for 30,000 shares

Context share figure 14,217,852 shares Figure presented alongside the 30,000-share planned sale as of 08/18/2026

Recent shares sold (3 months) 12,000 shares Total Xos common shares sold by Stuart Bernstein from 05/20/2026 to 06/30/2026

Proceeds 05/20/2026 sale $8,003 Aggregate proceeds from sale of 4,000 shares on 05/20/2026

Proceeds 06/04/2026 sale $21,029 Aggregate proceeds from sale of 4,000 shares on 06/04/2026

Proceeds 06/05/2026 sale $10,000 Aggregate proceeds from sale of 2,000 shares on 06/05/2026

Proceeds 06/30/2026 sale $5,780 Aggregate proceeds from sale of 2,000 shares on 06/30/2026

Key Terms

Rule 144, RSU Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU Vesting financial

"Common Stock | 06/22/2026 | RSU Vesting | Issuer"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

attorney-in-fact regulatory

"as attorney-in-fact for Stuart Bernstein"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What insider sale is being reported for XOS in this Rule 144 notice?

The notice states that director Stuart Bernstein plans to sell up to 30,000 shares of Xos, Inc. common stock under Rule 144. UBS Financial Services Inc. is listed as the broker handling the proposed sale.

How many XOS shares has Stuart Bernstein sold in the last three months?

Over the prior three months, Stuart Bernstein is listed as having sold a total of 12,000 shares of Xos common stock. These sales occurred on 05/20/2026, 06/04/2026, 06/05/2026, and 06/30/2026.

What were the aggregate proceeds from Stuart Bernstein’s recent XOS share sales?

The document lists aggregate proceeds of $8,003, $21,029, $10,000, and $5,780 for four transactions. Combined, these recent sales generated total proceeds of $44,812 for Xos common stock.

What RSU-related event is connected to the planned XOS share sale?

The planned sale of 30,000 shares is tied to RSU vesting on 06/22/2026. The source identifies the issuer, Xos, Inc., as the party associated with the RSU vesting event underlying these shares.

What contextual valuation figures are provided for the proposed XOS share sale?

A contextual line shows 30,000 shares with an aggregate market value of $124,500 and a related figure of 14,217,852 as of 08/18/2026. These figures illustrate scale and valuation around the proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 03:19 PM Accepted by SEC EDGAR 08/18/2026 - 03:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001873851
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Xos, Inc.
SEC File Number	001-39598
Address of Issuer	3550 Tyburn Street Los Angeles CALIFORNIA 90065
Phone	(818) 316-1890
Name of Person for Whose Account the Securities are To Be Sold	Stuart Bernstein
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	30000	124500	14217852	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/22/2026	RSU Vesting	Issuer			30000	06/22/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stuart Bernstein 3550 Tyburn Street Los Angeles CA 90065	Common Stock	05/20/2026	4000	8003
Stuart Bernstein 3550 Tyburn Street Los Angeles CA 90065	Common Stock	06/04/2026	4000	21029
Stuart Bernstein 3550 Tyburn Street Los Angeles CA 90065	Common Stock	06/05/2026	2000	10000
Stuart Bernstein 3550 Tyburn Street Los Angeles CA 90065	Common Stock	06/30/2026	2000	5780

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Stuart Bernstein
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)